Laidlaw Venture Partners Continues Strategic Growth with Addition of Jeff Conroy and George Serafin to its Board of Advisors

Laidlaw Venture Partners, the venture capital arm of Laidlaw & Company (UK) Ltd., today announced the addition of Jeff Conroy and George Serafin to its Board of Advisors. As industry leaders in Business Development and Regulatory/Compliance, both Conroy and Serafin bring years of strategic experience to Laidlaw Venture Partners and will be instrumental in the development and evolution of our innovative companies.

See Press Release Here

Laidlaw Venture Partners Continues Strategic Growth with Addition of Jeff Conroy and George Serafin to its Board of Advisors2020-06-25T19:00:05+00:00

Laidlaw served as Sole Book-Runner on the $5mm Follow-On Offering for Hoth Therapeutics (HOTH)

Laidlaw Capital Markets is pleased to announce yesterday’s pricing of a $5,000,000 Follow-On Offering for Hoth Therapeutics (HOTH). Laidlaw proudly served as the Sole Book Runner on the transaction.

See Press Release
Laidlaw served as Sole Book-Runner on the $5mm Follow-On Offering for Hoth Therapeutics (HOTH)2020-06-01T15:13:22+00:00

Laidlaw served as Introducing Broker on the $10.8mm financing for Biosig Technologies (BSGM), through its subsidiary ViralClear.

Laidlaw Venture Partners client Biosig Technologies (BSGM) through its newly formed subsidiary ViralClear, closes $10,800,000 financing. Laidlaw is proud to have acted as am Introducing Broker on this financing.

See Press Release
Laidlaw served as Introducing Broker on the $10.8mm financing for Biosig Technologies (BSGM), through its subsidiary ViralClear.2020-06-01T15:29:30+00:00

Laidlaw served as Co-Lead Manager on the $22mm financing and uplisting for Delcath Systems (DCTH)

Laidlaw Capital Markets is pleased to have acted as Co-Lead Manager on Delcath Systems’ (DCTH) $22,000,000 financing and uplisting to NASDAQ. Laidlaw proudly served as the Sole Book Runner on the transaction.

See Press Release
Laidlaw served as Co-Lead Manager on the $22mm financing and uplisting for Delcath Systems (DCTH)2020-06-01T15:25:48+00:00

Laidlaw served as Financial Advisor on the $70mm Follow-On Offering for Arcturus Therapeutics (ARCT).

Laidlaw Capital Markets is pleased to announce today’s pricing of a $70,000,000 Follow-On Offering for Arcturus Therapeutics (ARCT) around its Covid-19 vaccine and platform for other diseases. Laidlaw proudly served as Financial Advisor alongside Guggenheim, who was Sole-Book Runner on the transaction.

Laidlaw served as Financial Advisor on the $70mm Follow-On Offering for Arcturus Therapeutics (ARCT).2020-06-01T15:21:16+00:00

Laidlaw & Company enhances their Wealth Management offering with Envestnet | MoneyGuide

Laidlaw & Company enhances their Wealth Management offering with Envestnet | MoneyGuide

NEW YORK, NY, UNITED STATES, March 11, 2020 /EINPresswire.com/ — Laidlaw Wealth Management is pleased to announce it has chosen Envestnet, a leading provider of intelligent systems for wealth management and financial wellness, to provide Laidlaw advisors with access to their leading, comprehensive financial planning program; MoneyGuidePro®.

Helping clients define and prioritize goals helps them put their financial decisions into perspective. MoneyGuidePro helps clients define and prioritize their goals into needs, wants and wishes. It is designed for advisors with the client in mind; providing sophisticated solutions and smart assumptions to help advisors navigate the complex financial elements of their clients’ lives.

Rick Calhoun, CEO of Laidlaw Wealth Management stated, “we did a lot of due diligence on the planning applications available, to provide our clients with the best solution for their financial wellness and determined that MoneyGuidePro is it.” He went on to say, “we also identified and agreed with their motto: Everyone needs and deserves a quality financial plan®.”

Envestnet | MoneyGuide is dedicated to this mission – and focuses exclusively on helping advisors use financial planning to more effectively motivate each client to create, implement and maintain an investment strategy that best meets their lifetime financial goals.

Scott Abry
Abry Advisors, LLC
+1 203-253-6018
email us here

See press release at EIN Presswire here
Laidlaw & Company enhances their Wealth Management offering with Envestnet | MoneyGuide2020-03-17T00:29:13+00:00

Laidlaw served as Co-Manager on the $21.75mm EyePoint Pharmaceuticals (EYPT) Follow-On Offering.

Laidlaw Capital Markets is pleased to announce today’s pricing of a $21,750,000 Follow-On Offering for EyePoint Pharmaceuticals (EYPT). Laidlaw proudly served as Co-Manager alongside Guggenheim, who was Sole Book-Runner on the transaction.

See full Press Release on Eyepoint Website
Laidlaw served as Co-Manager on the $21.75mm EyePoint Pharmaceuticals (EYPT) Follow-On Offering.2020-02-21T20:40:43+00:00

Laidlaw served as Sole Book-Runner on the $10mm BioSig Technologies (BSGM) Follow-On Offering.

Laidlaw Capital Markets is pleased to announce today’s pricing of a $10,000,000 Follow-On Offering for BioSig Technologies (BSGM). Laidlaw proudly served as the Sole Book Runner on the transaction.

 

See full Press Release on BioSig Website
Laidlaw served as Sole Book-Runner on the $10mm BioSig Technologies (BSGM) Follow-On Offering.2020-02-21T20:30:59+00:00

Laidlaw served as Co-Manager on the $90mm Ziopharm Oncology (ZIOP) Follow-On Offering

Laidlaw Capital Markets is pleased to announce today’s pricing of a $90,000,000 Follow-On Offering for Ziopharm Oncology (ZIOP). Laidlaw proudly served as Co-Manager alongside Jefferies, who was Sole-Book Runner on the transaction.

See full Press Release on Ziopharm Website
Laidlaw served as Co-Manager on the $90mm Ziopharm Oncology (ZIOP) Follow-On Offering2020-02-05T19:29:57+00:00

Laidlaw served as Financial Advisor on the $11.5mm Beyond Air (XAIR) Follow-On Offering

The Laidlaw Capital Markets team is pleased to announce our role as a Financial Advisor to Beyond Air Inc (XAIR) on this mornings $11,500,000 Follow-On Offering led by Suntrust Robinson. Laidlaw acted as Sole Placement Agent on a $10,000,000 PIPE in 2018 and this is the third transaction we have been involved in with the company.

See full Press Release on Beyond Air Website

 

Laidlaw served as Financial Advisor on the $11.5mm Beyond Air (XAIR) Follow-On Offering2020-01-14T23:05:11+00:00
Go to Top